Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M403589200 on June 28, 2004

J. Biol. Chem., Vol. 279, Issue 39, 40802-40806, September 24, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/39/40802    most recent
M403589200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fuda, C.
Right arrow Articles by Mobashery, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fuda, C.
Right arrow Articles by Mobashery, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Basis for Resistance to {beta}-Lactam Antibiotics by Penicillin-binding Protein 2a of Methicillin-resistant Staphylococcus aureus*

Cosimo Fuda, Maxim Suvorov, Sergei B. Vakulenko, and Shahriar Mobashery{ddagger}

From the Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556

Penicillin-binding protein 2a (PBP2a) of Staphylococcus aureus is refractory to inhibition by available {beta}-lactam antibiotics, resulting in resistance to these antibiotics. The strains of S. aureus that have acquired the mecA gene for PBP2a are designated as methicillin-resistant S. aureus (MRSA). The mecA gene was cloned and expressed in Escherichia coli, and PBP2a was purified to homogeneity. The kinetic parameters for interactions of several {beta}-lactam antibiotics (penicillins, cephalosporins, and a carbapenem) and PBP2a were evaluated. The enzyme manifests resistance to covalent modification by {beta}-lactam antibiotics at the active site serine residue in two ways. First, the microscopic rate constant for acylation (k2) is attenuated by 3 to 4 orders of magnitude over the corresponding determinations for penicillin-sensitive penicillin-binding proteins. Second, the enzyme shows elevated dissociation constants (Kd) for the non-covalent pre-acylation complexes with the antibiotics, the formation of which ultimately would lead to enzyme acylation. The two factors working in concert effectively prevent enzyme acylation by the antibiotics in vivo, giving rise to drug resistance. Given the opportunity to form the acyl enzyme species in in vitro experiments, circular dichroism measurements revealed that the enzyme undergoes substantial conformational changes in the course of the process that would lead to enzyme acylation. The observed conformational changes are likely to be a hallmark for how this enzyme carries out its catalytic function in cross-linking the bacterial cell wall.


Received for publication, March 31, 2004 , and in revised form, June 1, 2004.

* This work was supported by National Institutes of Health Grant GM61629. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed. Tel.: 574-631-2933; Fax: 574-631-6652; E-mail: mobashery{at}nd.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
M. Chung, A. Antignac, C. Kim, and A. Tomasz
Comparative Study of the Susceptibilities of Major Epidemic Clones of Methicillin-Resistant Staphylococcus aureus to Oxacillin and to the New Broad-Spectrum Cephalosporin Ceftobiprole
Antimicrob. Agents Chemother., August 1, 2008; 52(8): 2709 - 2717.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
L. R. R. Perez, C. Dias, and P. A. d'Azevedo
Agar dilution and agar screen with cefoxitin and oxacillin: what is known and what is unknown in detection of meticillin-resistant Staphylococcus aureus
J. Med. Microbiol., August 1, 2008; 57(8): 954 - 956.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Lemaire, C. Fuda, F. Van Bambeke, P. M. Tulkens, and S. Mobashery
Restoration of Susceptibility of Methicillin-resistant Staphylococcus aureus to {beta}-Lactam Antibiotics by Acidic pH: ROLE OF PENICILLIN-BINDING PROTEIN PBP 2a
J. Biol. Chem., May 9, 2008; 283(19): 12769 - 12776.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Fan, Y. Liu, D. Smith, L. Konermann, K. W. M. Siu, and D. Golemi-Kotra
Diversity of Penicillin-binding Proteins: RESISTANCE FACTOR FmtA OF STAPHYLOCOCCUS AUREUS
J. Biol. Chem., November 30, 2007; 282(48): 35143 - 35152.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
D.-H. Kwon and C.-D. Lu
Polyamine Effects on Antibiotic Susceptibility in Bacteria
Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2070 - 2077.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. Lemaire, F. Van Bambeke, M.-P. Mingeot-Leclercq, Y. Glupczynski, and P. M. Tulkens
Role of Acidic pH in the Susceptibility of Intraphagocytic Methicillin-Resistant Staphylococcus aureus Strains to Meropenem and Cloxacillin
Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1627 - 1632.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Fuda, D. Hesek, M. Lee, W. Heilmayer, R. Novak, S. B. Vakulenko, and S. Mobashery
Mechanistic Basis for the Action of New Cephalosporin Antibiotics Effective against Methicillin- and Vancomycin-resistant Staphylococcus aureus
J. Biol. Chem., April 14, 2006; 281(15): 10035 - 10041.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement